Meeting Details

The 28th Annual General Meeting of the Company was held on Wednesday, July 29, 2026. The meeting commenced at 10:00 A.M. (IST) and concluded at 11:00 P.M. (IST). It was conducted through Video Conference (VC)/ Other Audio-Visual Means (OAVM) in compliance with the Companies Act, 2013 and relevant circulars from the Ministry of Corporate Affairs and SEBI.

Attendance

Directors and Key Managerial Personnel Present:

The following individuals were present, all from Hyderabad, India:

  • Dr. Ramesh Kancharla - Chairman & Managing Director, Chairman of Business Strategy & Investment Committee and Treasury Management Committee, and Member of Risk Management Committee, Stakeholders Relationship Committee, CSR & ESG Committee and TCWG Committee.
  • Dr. Dinesh Kumar Chirla - Whole-Time Director and Member of CSR & ESG Committee.
  • Dr. Adarsh Kancharla - Non-Executive Director and Member of Risk Management Committee and CSR & ESG Committee.
  • Dr. Anil Dhawan - Independent Director, Chairman of CSR & ESG Committee and member of Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee and TCWG Committee.
  • Mr. Aluri Srinivasa Rao - Independent Director, Chairman of Nomination & Remuneration Committee and member of Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee, and TCWG Committee.
  • Mr. Santanu Mukherjee - Independent Director, Chairman of Audit Committee and Risk Management Committee and member of Nomination & Remuneration Committee, CSR & ESG Committee, Treasury Management Committee, Business Strategy & Investment Committee and TCWG Committee.
  • Ms. Sundari R. Pisupati - Independent Director, Chairperson of Stakeholders Relationship Committee and member of Audit Committee, Nomination & Remuneration Committee and CSR & ESG Committee.
  • Mr. Abrarali Dalal - Chief Executive Officer and Member of Risk Management Committee, Business Strategy & Investment Committee and TCWG Committee.
  • Mr. Vikas Maheshwari - Chief Financial Officer and Member of Risk Management Committee, Treasury Management Committee and TCWG Committee.
  • Ms. Shreya Mitra - Company Secretary & Compliance Officer.

Member Attendance:

A total of 63 members were present at the meeting.

  • Promoter & Promoter Group: 6
  • Public: 57

Other Attendees:

The following representatives of the company's auditors were also present:

  • Mr. Chirag C Shah - Director, M/s. S.R. Batliboi & Associates LLP, Statutory Auditors.
  • Mr. K.V.S Subramanyam - Practicing Company Secretary, Secretarial Auditor.
  • Mr. Prabhat Naulakha - Associate Director, M/s. Deloitte Touche Tohmatsu India LLP, Internal Auditors.
  • Ms. K.V.N. Lavanya - Designated Partner, M/s. Lavanya and Associates LLP, Cost Accountants, Cost Auditors.

Summary of Proposed Resolutions

The following business items were taken up as per the Notice of the AGM:

ORDINARY BUSINESS:

1. Adoption of the Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2026, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2026 and the report of the Auditors thereon.

2. To declare a dividend of ₹3.5 per Equity Share for the Financial Year ended March 31, 2026.

3. To appoint a Director in place of Dr. Adarsh Kancharla (DIN: 08302615), who retires by rotation and being eligible offers himself for re-appointment.

SPECIAL BUSINESS:

4. To ratify the remuneration payable to Cost Auditors for the Financial Year 2026-27.

5. To consider, review and approve the re-appointment of Dr. Ramesh Kancharla (DIN: 00212270), Chairman and Managing Director of the Company.

6. To consider, review and approve the remuneration payable to Dr. Ramesh Kancharla (DIN: 00212270), as Chairman and Managing Director of the Company.

7. To consider, review and approve the re-appointment of Dr. Dinesh Kumar Chirla (DIN: 01395841), Whole-time Director of the Company.

8. To consider and approve the payment of remuneration to Dr. Dinesh Kumar Chirla (DIN: 01395841), Whole-time Director of the Company.

9. To consider, approve and recommend for the re-appointment of Mr. Santanu Mukherjee (DIN: 07716452), as an Independent Director of the Company.

10. To consider, approve and recommend for the re-appointment of Ms. Sundari R. Pisupati (DIN: 01908852), as an Independent Director of the Company.

Voting Process

  • The Board of Directors engaged the services of National Securities Depository Limited (NSDL) to provide the e-voting facility.
  • The Company provided a remote e-voting facility to all Members. The remote e-voting period commenced on Saturday, July 25, 2026, at 9:00 A.M. and ended on Tuesday, July 28, 2026, at 5:00 P.M.
  • Members who had not cast their votes via remote e-voting were permitted to cast their votes during the meeting through the e-voting system provided by NSDL.
  • The Board of Directors appointed Mr. K.V.S Subramanyam (C P No.: 4815), Designated Partner of M/s. KVSS & CO. LLP (Formerly BS and Co LLP), a Practicing Company Secretary Firm, as the Scrutinizer. His role was to scrutinize the remote e-voting and e-voting process during the AGM in a fair and transparent manner.

Key Voting Outcomes

The results of the e-voting conducted at the AGM, aggregated with the results of remote e-voting, were to be announced on or before July 31, 2026. These results were to be made available on the website of the Company, the websites of BSE Limited and National Stock Exchange of India Limited, and the website of NSDL. The specific vote counts and percentages were not provided in this proceeding document.

Compliance Confirmation

The meeting was confirmed to have been conducted in compliance with the applicable provisions of the Companies Act, 2013 and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The Chairman confirmed that the Statutory Auditors' Report and Secretarial Auditors' Report for the Financial Year ended March 31, 2026, contained no qualifications, observations, or comments on financial transactions or matters which had an adverse effect on the functioning of the Company.